Trans-catheter aortic valve replacement (tavr) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue American Journal of Transplantation Année : 2020

Trans-catheter aortic valve replacement (tavr) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients

Résumé

Severe aortic stenosis is a widespread valve disease, constituting a contraindication to organ transplantation due to cardiovascular morbidity and projected mortality. Mortality after conventional surgical aortic valve replacement in cirrhotic patients depends upon the Child-Pugh class. In the past few years, transcatheter aortic valve replacement has progressively become the treatment of choice for high-risk patients with severe aortic stenosis. Here, we report the cases of 3 cirrhotic patients who became eligible for liver transplantation after successful transcatheter aortic valve replacement as bridge therapy.

Dates et versions

hal-03534077 , version 1 (19-01-2022)

Identifiants

Citer

Clementine Levy, Guillaume Lassailly, Mehdi El Amrani, Flavien Vincent, Cedric Delhaye, et al.. Trans-catheter aortic valve replacement (tavr) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients. American Journal of Transplantation, 2020, American journal of transplantation official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 20 (9), pp.2567-2570. ⟨10.1111/ajt.15955⟩. ⟨hal-03534077⟩
15 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More